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Bone morphogenetic protein-2Sonic hedgehog signaling in the secondary heart ﬁeld has a clear role in cardiac arterial pole development. In
the absence of hedgehog signaling, proliferation is reduced in secondary heart ﬁeld progenitors, and embryos
predominantly develop pulmonary atresia. While it is expected that proliferation in the secondary heart ﬁeld
would be increased with elevated hedgehog signaling, this idea has never been tested. We hypothesized that
up-regulating hedgehog signaling would increase secondary heart ﬁeld proliferation, which would lead to
arterial pole defects. In culture, secondary heart ﬁeld explants proliferated up to 6-fold more in response to
the hedgehog signaling agonist SAG, while myocardial differentiation and migration were unaffected.
Treatment of chick embryos with SAG at HH14, just before the peak in secondary heart ﬁeld proliferation,
resulted unexpectedly in stenosis of both the aortic and pulmonary outlets. We examined proliferation in the
secondary heart ﬁeld and found that SAG-treated embryos exhibited a much milder increase in proliferation
than was indicated by the in vitro experiments. To determine the source of other signaling factors that could
modulate increased hedgehog signaling, we co-cultured secondary heart ﬁeld explants with isolated
pharyngeal endoderm or outﬂow tract and found that outﬂow tract co-cultures prevented SAG-induced
proliferation. BMP2 is made and secreted by the outﬂow tract myocardium. To determine whether BMP
signaling could prevent SAG-induced proliferation, we treated explants with SAG and BMP2 and found that
BMP2 inhibited SAG-induced proliferation. In vivo, SAG-treated embryos showed up-regulated BMP2
expression and signaling. Together, these results indicate that BMP signaling from the outﬂow tract modulates
hedgehog-induced proliferation in the secondary heart ﬁeld., NC 27710, USA. Fax: +1 919
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
As the heart loops, the splanchnic mesoderm, located between the
outﬂow and inﬂow attachments to the ventral pharynx, contributes
ﬁrst the myocardium and then the smooth muscle that forms the
arterial pole (Waldo et al., 2005). This region of arterial pole-forming
splanchnic mesoderm is called the secondary heart ﬁeld. As some of
the secondary heart ﬁeld progenitors differentiate, others continue to
proliferate to generate enough cells to provide both myocardium and
smooth muscle to the arterial pole (van den Berg et al., 2009). These
proliferative cells are located more caudally in the ﬁeld and are
adjacent to the pharyngeal endoderm, which produces Sonic
hedgehog (Shh), a secreted ligand (Dyer and Kirby, 2009). The
cardiac progenitors in the secondary heart ﬁeld express the Shh
receptor Patched2 (Ptc2). Interestingly, Ptc2 expression is more
robust in the caudal secondary heart ﬁeld, which is the region of
highest proliferation (Dyer and Kirby, 2009).Shh is a knownmitogen and cell survival factor (reviewed in Ingham
and McMahon, 2001). Among its downstream targets are cell cycle
genes such as cyclins D1 and E and n-myc, which promote the G1 to S
transition (Kenney and Rowitch, 2000; Oliver et al., 2003). Inhibiting
Shh signaling stalls limb bud mesenchyme cells in G1, with fewer cells
progressing to S phase (Zhu et al., 2008).
Recently, our lab and others have shown that Shh signaling is
required for normal arterial pole development. The Shh-null mouse has
pulmonary atresia (Washington Smoak et al., 2005), as do chick
embryos treated with the Shh inhibitor cyclopamine (Dyer and Kirby,
2009). A Shh conditional knockout in theNkx2.5 expression domain has
a single outﬂow vessel (Goddeeris et al., 2007). In the chick, inhibiting
hedgehog signaling at discrete stages associated with the production of
secondary heart ﬁeld-derived arterial pole myocardium reduced
secondary heart ﬁeld proliferation and resulted in pulmonary atresia/
stenosis (Dyer andKirby, 2009). However, nothing is knownaboutwhat
happens when the secondary heart ﬁeld is exposed to excess hedgehog
signaling. The function of Shh is context-dependent, and both the dose
and timingof Shh exposure are critical duringdevelopment (Harfe et al.,
2004; Scherz et al., 2007; Yang et al., 1997; Zhu et al., 2008).
Because blocking hedgehog signaling led to pulmonary atresia/
stenosis by decreasing proliferation in the secondary heart ﬁeld, we
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proliferation throughout the secondary heart ﬁeld, whichwould also lead
to abnormal arterial pole development. To determine the effect of Shh
signaling on secondary heart ﬁeld, we treated secondary heart ﬁeld
explants with SAG, a hedgehog agonist. The explants showed a robust
increase in proliferation in response to SAG. By contrast, when treating
embryos in ovo, SAG only increased proliferation transiently and was
quickly suppressed. As a result, the ﬁnal arterial pole phenotype was a
mild stenosis of both the aortic and pulmonary outlets after septation. To
determine what interactions moderated increased hedgehog signaling,
we co-cultured secondary heart ﬁeld explants with isolated pharyngeal
endoderm or outﬂow tract myocardium. Outﬂow tract co-cultured with
secondary heart ﬁeld explants suppressed SAG-induced proliferation and
promoted myocardial differentiation. The outﬂow tract is a source of
BMP2, which promotes myocardial differentiation and can also inhibit
Shh-induced proliferation. Secondary heart ﬁeld explants treated with
SAG and BMP2 showed increased myocardial differentiation, with no
increase in proliferation. In vivo, BMP2 expression was elevated at the
junction of the outﬂow tract with the pharynx, and phosphorylated
SMAD1,5,8was up-regulated in the secondary heart ﬁeld.When embryos
were treated with SAG and dorsomorphin, a BMP antagonist, early
embryonic lethality resulted. Together, these data show that BMP
signaling fromtheoutﬂowtract regulateshedgehog-inducedproliferation
in the secondary heart ﬁeld and that a tightly synchronized rate of
proliferation is required for normal arterial pole development.
Methods and Materials
Embryos
Fertilized Ross Hubert chick eggs (Gallus gallus domesticus,
Pilgrim's Pride Hatchery, Siler City, NC) were incubated for 1-9 days
at 37 °C and 70% humidity. Embryos were staged according to
Hamburger and Hamilton (1951).
Secondary heart ﬁeld explants
Secondary heart ﬁeld explants were isolated at HH14 as previously
described (Dyer and Kirby, 2009). Hedgehog signaling was up-
regulated by applying the Smoothened agonist SAG (Calbiochem, San
Diego, CA). In vitro doses were based on a previous report (Chen et al.,
2002), where 100 nM showed peak signaling activity in a hedgehog
reporter cell line. A range of doses from 50-200 nMwas tested in vitro.
Some cultures were also treated with 300 ng/ml recombinant BMP2
(R&D Systems, Minneapolis, MN).
Migration of explanted secondary heart ﬁeld cells was analyzed
over a 16-hour period as previously described (Dyer and Kirby, 2009).
A minimum of six explants per treatment were recorded, and ANOVA
and pair-wise Student's t-test were used to determine statistical
signiﬁcance. Proliferation in the explants was assessed using BrdU
(Roche, Indianapolis, IN) incorporation as previously described (Dyer
and Kirby, 2009). Four to seven explants per dose were counted, and
the Kruskal-Wallis test was used to determine statistical signiﬁcance.
To determine what effects the pharyngeal endoderm and the
outﬂow tract have on the secondary heart ﬁeld, a series of secondary
heart ﬁeld explants were co-cultured with pharyngeal endoderm or
outﬂow tract explants or 2% FBS/DMEM in the presence or absence of
100 nM SAG. After 24 h, explants were ﬁxed in cold methanol and
labeled with mitotic marker pHH3 (Millipore, Billerica, MA), myocar-
dial marker MF20 (Developmental Studies Hybridoma Bank, Iowa
City, IA), and DAPI (Molecular Probes, Invitrogen). The number of
pHH3- and MF20-positive cells was counted with Acapella (Perkin
Elmer, Waltham, MA), and a minimum of six explants per condition
were counted. The Kruskal-Wallis test was used to determine
statistical signiﬁcance.Enhanced hedgehog signaling in the secondary heart ﬁeld in vivo
Eggs were windowed at HH14, and 10 μl of increasing concentra-
tions of SAG or H2O (control) was pipetted onto the embryo; eggs
were sealed with tape and incubated. Stock SAG was dissolved and
diluted in distilled H2O.
To determine the phenotypic outcome in the four-chambered
heart, control and treated embryos were harvested at HH35,
photographed, ﬁxed in methacarn overnight at 4 °C, parafﬁn-
embedded, and labeled with MF20, smooth muscle marker SM22-α
(Abcam, Cambridge, MA), and DAPI. In addition, the heart weight/
body weight ratio was determined at HH35. Brieﬂy, hearts were
excised, and both heart weight and total body weight were recorded.
Hearts and bodies were re-weighed after dehydration by baking, and
Student's t-test was used to determine statistical signiﬁcance.
Arterial pole lumenal areas were quantiﬁed in transverse histo-
logical sections of control and treated hearts using ImageJ (Rasband,
W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland,
USA, http://rsb.info.nih.gov/ij/, 1997-2009). Brieﬂy, the rounded
apices of the hearts were removed to provide a consistent orientation
for embedding. Sections (10 μm) were photographed at 4x magniﬁ-
cation. The luminal areas of the aortic vestibule, the pulmonary
infundibulum, and the semilunar valves were quantiﬁed. To ensure
that comparable regions were measured, the aortic vestibule and
pulmonary infundibulummeasurements were restricted to the 80 μm
below the ﬁrst valve leaﬂet. The semilunar valve measurements were
only collected in regions that had all three valve leaﬂets present and
spanned 50-140 μm in length, and there were no signiﬁcant
differences between the length of this region and treatment. A
minimum of three embryos per treatment was measured, and
Student's t-test was used to determine statistical signiﬁcance.
Reverse transcription quantitative PCR (RT-qPCR)
RNA was isolated using the Qiagen RNeasy kit (Qiagen, Valencia,
CA) from freshly isolated explants or after various times in culture
with various treatments. RT and qPCR for Ptc1 and Ptc2 were carried
out as described in Dyer and Kirby (2009). Tested genes included
known Shh targets, myocardial differentiation markers, and heart
ﬁeld markers. All primers are listed in Supplemental Table 1, and
HPRT was used as a reference gene. Data are presented as the log2-
transformed expression ratios; thus, any log2-tranformed expression
ratio above 1 or less than -1 represents at least a 2-fold change in
expression compared to the control.
Immunohistochemical analyses
Secondary heart ﬁeld proliferation was analyzed in control and
SAG-treated embryos at HH15-18 as described (Dyer and Kirby,
2009). In addition, in vivo secondary heart ﬁeld migration was
analyzed based on Hnk1 expression at HH16 and HH18. To analyze
BMP signaling, control and SAG-treated embryos were also labeled
with antibodies against pSMAD1,5,8 (Cell Signaling Technology,
Danvers, MA) and BMP2. All immunohistochemistry was performed
as described previously (Waldo et al., 1996), with the exception that
embryos labeled with pSMAD1,5,8 were ﬁxed in ice-cold 4%
paraformaledyhde in PBS containing 0.1% Tween 20.
In situ hybridization
In situ hybridization was carried out using a probe generated from
a Ptc2 plasmid generously provided by Cliff Tabin (Harvard Univer-
sity, Cambridge, MA). For BMP2 expression, a 337-bp fragment of
Gallus gallus BMP2 (accession number x75914) was ampliﬁed using
cDNA from HH14 and HH18 chick embryonic hearts and inserted into
vector pCRII. The plasmid was linearized with KpnI, and antisense
Fig. 1. Increased hedgehog signaling results in up-regulation of a cell cycle gene and
proliferation within the secondary heart ﬁeld. (A) qPCR was carried out on explants
that were cultured for 6 hours with or without SAG. The expression ratios are compared
to control explants, and all results were normalized to HPRT expression. Hedgehog
receptors Ptc1 and Ptc2, as well as cell cycle gene cyclin D1 (CCND1), are signiﬁcantly
up-regulated after SAG treatment. Nkx2.5, troponin T (TNNT2) and cardiac α-actin
(Actc1) were not signiﬁcantly up-regulated by SAG treatment. All samples were run in
triplicate, and the average and standard error of three independent experiments is
shown. All data are log2-transformed; thus, values over 1 or less than -1 represent 2-
fold differences. (B-C) Up-regulating hedgehog signaling induces proliferation in a
dose-dependent manner and does not affect migration. Explants were treated with
increasing doses of SAG, and proliferation, indicated by BrdU incorporation, increases
up to 6-fold as compared to control embryos. No statistically signiﬁcant changes were
observed in myocardial differentiation as indicated by MF20 expression (B) or
migration (C). A minimum of six explants per condition were analyzed; Kruskal-Wallis
or ANOVA were used to determine statistical signiﬁcance, followed by secondary
analysis as necessary. *pb0.05, **pb0.01.
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T7 as the 3’ primer. The PCR product was puriﬁed with Qiagen
QIAquick PCR Puriﬁcation Kit and then used to generate RNA probeTable 1
Survival and arterial pole malformations after SAG treatment at HH14.
Treatment N Survival (%) Abnormal Outﬂow (%)
H2O 11 10 (91%) 0
344 μM SAG 21 17 (81%) 11 (65%)
672 μM SAG 6 1 (17%) 1 (100%)
1,000 μM SAG 13 2 (15%) 1 (50%)with the Roche DIG RNA labeling Kit (SP6/T7). The resulting DIG-
labeled RNA BMP2 probe was cleaned up by LiCl/EtOH precipitation
and veriﬁed by gel and dot blot.
Control and SAG-treated embryos were harvested at HH16 in
DEPC-treated 4% paraformaldehyde. In situ hybridization was carried
out as described by Wilkinson (1992).
Statistical analysis
Microsoft Excel and R (http://www.r-project.org) were used for
statistical analysis. In all analyses, a p-value b0.05 was used as the
mark of statistical signiﬁcance.
Results
Explanted secondary heart ﬁeld proliferates in response to elevated
hedgehog signaling
To determine whether the hedgehog agonist SAG could up-
regulate hedgehog signaling in the secondary heart ﬁeld, secondary
heart ﬁeld mesoderm was explanted and cultured with or without
SAG for 6 h. Ptc1 and Ptc2 are hedgehog receptors that are also
downstream targets of hedgehog signaling. Expression of both
receptors was signiﬁcantly up-regulated in secondary heart ﬁeld
explants in response to SAG by qPCR analysis (Fig. 1A). In addition,
Shh-induced cell cycle gene cyclin D1 (CCND1) was signiﬁcantly up-
regulated in response to SAG. However, cell cycle gene N-myc, cardiacFig. 2. Ptc2 mRNA is up-regulated in vivo in response to SAG treatment. (A, B) Ptc2
mRNA expression at HH16. Ptc2 is expressed in the secondary heart ﬁeld (SHF), with
strongest expression in the caudal SHF (A, arrows). After treatment with hedgehog
agonist SAG at HH14, Ptc2 expression is increased (B) compared to water-treated
controls (A). (C) Ptc2 up-regulation was conﬁrmed with RT-qPCR. Embryos were
treated with water or SAG at HH14, and RNA was extracted from SHF explants at HH16.
Gene expression was normalized to HPRT, and data are presented as the log2-transform
of the expression ratios. Thus, values greater than 1 indicate at least 2-fold changes in
expression. All samples were run in triplicate, and the average and standard error of
three independent experiments is shown. (PE, pharyngeal endoderm; SHF, secondary
heart ﬁeld; OFT, outﬂow tract).
Fig. 3. Proliferation is minimally disrupted in response to increased hedgehog signaling in vivo. Proliferation is initially increased and then decreased in the caudal secondary heart
ﬁeld (SHF) after hedgehog up-regulation. Embryos were treated with water (Control) or SAG at HH14 and BrdU-treated at the stages indicated. (A,B) Sections were labeled with
MF20 (myocardium, red), anti-BrdU (proliferating cells, green), and DAPI (nuclei, blue). Proliferating cells were counted in 10-cell increments, starting at the junction of the outﬂow
tract (OFT) and moving caudally. No changes were observed at HH15 (C). By HH16, SAG-treated embryos showed elevated BrdU incorporation in the caudal SHF as compared to
control embryos (D). This increase was no longer present by HH17 (E), and no changes were observed at HH18 (F). PE, pharyngeal endoderm. *pb0.05, Student's t-test.
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markers myosin heavy chain (Myh6), troponin T (TNNT2), and
cardiac alpha-actin (Actc1), were not affected by SAG treatment
(Fig. 1A and data not shown).
Because down-regulating hedgehog signaling results in decreased
proliferation (Dyer and Kirby, 2009) and up-regulating hedgehog
signaling induced cyclin D1, we examined whether proliferation was
increased by SAG. Secondary heart ﬁeld explants excised at HH14
were cultured with 50-200 nM SAG. Proliferation, as measured by
BrdU incorporation, increased signiﬁcantly in a dose-dependent
manner, from 3% of cells in control explants to 22% in response to
increasing doses of SAG (pb0.01) (Fig. 1B).
Neither myocardial differentiation (Fig. 1B, indicated by MF20
expression) nor the migration index (the area over which the explant
spread normalized by the perimeter of the explant at the end of the
experiment, Fig. 1C) was signiﬁcantly affected by increased hedgehog
signaling. Together, these data support the hypothesis that hedgehog
signaling promotes proliferation in the secondary heart ﬁeld.Secondary heart ﬁeld in vivo shows aweak proliferative response to elevated
hedgehog signaling
To determinewhether SAG up-regulates hedgehog signaling in vivo,
embryoswere treated atHH13-14with SAG. The only previous report of
SAG use in vivo (2.6 mM) was in pregnant mice with subsequent
examination of upregulated Ptc1-lacZ in embryos (Frank-Kamenetsky
et al., 2002). Because we were applying the drug directly to chick
embryos, lower doses ranging from 344 to 1,000 μM were tested
(Table 1 and data not shown). Doses in excess of 344 μM (0.2 mg/ml)
were lethal within 12 hours; thus, 344 μM was chosen for further
analysis.
At HH14, embryos were treated with either 344 μM SAG or H2O as
a control and collected at HH16 for in situ hybridization. Ptc2
expression was up-regulated in the secondary heart ﬁeld of SAG-
treated embryos (Fig. 2B) compared to control embryos (Fig. 2A)
indicating that the secondary heart ﬁeld did experience elevated
hedgehog signaling. In addition, Ptc1 and Ptc2 expression was
Fig. 4. Up-regulated hedgehog signaling causes arterial pole stenosis. Embryos were treated with water (Control, A, C, E) or SAG (B, D, F) at HH14 and developed to HH35. Treated
embryos appeared to have a narrower arterial pole (compare B and A), despite having a higher heart weight/body weight ratio (G). Stenosis was conﬁrmed in histological sections.
Sections were labeled with MF20 (myocardium, red), α-SM22 (smooth muscle, green), and DAPI (nuclei, blue). Below the outﬂow tract valves, both the pulmonary infundibulum
(PI) and aortic vestibule (AoV) were signiﬁcantly smaller in SAG-treated embryos (D) than in control embryos (C). At the level of the outﬂow tract valves, both the pulmonary artery
(P) and aorta (Ao) were signiﬁcantly smaller in treated embryos (F) as compared to control embryos (E). (H,I) Area measurement is 104 um2. N=4 controls and 9 SAG-treated
embryos. Student's t-test was used to calculate statistical signiﬁcance; *pb0.05.
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treated embryos using RT-qPCR. Ptc2 expression was signiﬁcantly
up-regulated at HH16 (pb0.05, Fig. 2C) in response to SAG treatment,
while Ptc1 was unchanged at this stage.
We examined proliferation in the secondary heart ﬁeld after
embryos were treated with SAG or H2O at HH14. Embryos were
labeled with BrdU and collected at HH15-18. The embryos were
sectioned sagittally to allow the cells in the secondary heart ﬁeld to be
counted. This mesoderm is a continuous layer extending from the
splanchnic mesoderm into the outﬂowmyocardium. The more caudal
region of the secondary heart ﬁeld mesoderm is pseudostratiﬁed, and
the cells reorganize to a stratiﬁed cell layer as they turn into the
outﬂow tract and begin to differentiate as myocardium (Fig. 3A). This
organization was subtly disrupted in SAG-treated embryos.
Normally, proliferation is greater in the caudal secondary heart
ﬁeld, adjacent to the Shh-producing pharyngeal endoderm, compared
to secondary heart ﬁeld cells that are closer to the outﬂow tract
(Fig. 3A and Dyer and Kirby, 2009). After SAG treatment, the highly
proliferative region appeared largely comparable to control embryos
(Fig. 3B).To quantify these observations, the number of proliferating cells
was counted in 10-cell increments, starting at the junction of the
secondary heart ﬁeld with the outﬂow tract. At HH15, no changes
were observed between control and treated embryos (Fig. 3C).
However, proliferationwas increased in a discrete region of secondary
heart ﬁeld by HH16 after treatment with SAG, as compared to control
embryos (Fig. 3C). Interestingly, this increased level of proliferation
was limited to this one region at a single time point. SAG-treated
embryos showed normal proliferation compared to their control
counterparts at HH17 and 18 (Fig. 3C). This unexpected weak
response to elevated hedgehog signaling in vivo suggests that
hedgehog signaling is counter-balanced by other factors in the
regulation of secondary heart ﬁeld proliferation.
Up-regulated hedgehog signaling results in aortic and pulmonary outﬂow
stenosis
Previous studies have shown that changes in secondary heart ﬁeld
proliferation result in arterial pole defects (Waldo et al., 2005; Xu
et al., 2004; Hutson et al., 2006). Even though up-regulated hedgehog
Fig. 5. Other tissues modulate Shh signaling. (A) Embryos were treated with H2O
(control) or SAG (SAG) at HH14. At HH15, secondary heart ﬁeld mesoderm was excised
for RT-qPCR. Results are presented as the log2-transformed expression ratio compared
to control HH15 secondary heart ﬁelds, and all values greater than 1 represent at least a
2-fold increase. Unlike the in vitro results after 6 hours of isolated culture, explants
from SAG-treated HH15 embryos showed signiﬁcant increases in Ptc1 and heart ﬁeld
marker Nkx2.5 compared to explants from control embryos while explants from HH16
embryos showed an increase in Ptc2 and signiﬁcant decreases in myocardial markers
troponin T (TNNT2) and alpha cardiac actin (ACTC1). All genes were normalized to
HPRT expression. (B, C) To determine how in vivo environment affects the secondary
heart ﬁeld, explants were co-cultured with pharyngeal endoderm or outﬂow tract in
the presence or absence of 100 nM SAG. When secondary heart ﬁeld mesoderm was
cultured by itself, SAG induced an up-regulation in proliferation (B) but not myocardial
differentiation (C). If explants were cultured with pharyngeal endoderm (PE) or
outﬂow tract (OFT), SAG could not up-regulate proliferation (B). Explants cultured with
pharyngeal endoderm showed increased myocardial differentiation, which was
inhibited by SAG, and explants cultured with OFT showed increased myocardial
differentiation regardless of whether SAG was present. *pb0.05.
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vivo, we examined whether the embryos might still have arterial pole
defects. Embryos were treated with 344 μM SAG or H2O at HH13-14
andwere allowed to develop until HH35. Of the SAG-treated embryos,
approximately 80% (n=17) survived to HH35. Analysis of the whole
mounts showed that the brachiocephalic arteries, which branch off
the aorta, were straighter in a signiﬁcant percentage of the treated
embryos (47% vs. 0% in controls, p=0.01, Fig. 4B). In addition, the
SAG-exposed hearts appeared to have narrower pulmonary and
systemic outlets compared to control embryos (compare Figs. 4Band A, n=10). However, the wet heart weight/body weight ratio was
signiﬁcantly higher in SAG-treated embryos than in control embryos,
suggesting that the SAG-treated hearts were actually larger than their
control counterparts (Fig. 4C). The increased ratio seen in SAG-treated
embryos was not caused by edema, as indicated by the fact that the
heart weight/body weight ratio tended towards being higher in the
SAG-treated embryos as compared to control embryos when hearts
and embryos were dehydrated. This increase in heart size potentially
represents a hypertrophic response to the narrowed outlets.
To quantify the smaller arterial outlets, hearts were transversely
sectioned and labeled with MF20 and smooth muscle marker SM22.
Because the secondary heart ﬁeld contributes both myocardium
below the semilunar valves and smooth muscle distal to the valves,
we focused on the size of the pulmonary infundibulum, the aortic
vestibule, and the outlets at the level of the valve leaﬂets. In SAG-
treated embryos, the aortic vestibule was reduced in size by 35%
(pb0.05), and the pulmonary infundibulum was reduced in size by
45% (pb0.05) compared to the control embryos (Figs. 4C, D, and H). At
the level of the valve leaﬂets, both SAG-treated outlets were reduced
by approximately 50% (pb0.05) as compared to control embryos
(Figs. 4E, F, and I).
In vivo context moderates secondary heart ﬁeld behavior
Based on the in vitro proliferation studies, the in vivo proliferation
response and the resulting phenotypes were unexpected. To under-
stand the response of the secondary heart ﬁeld more clearly, we
subjected dissected secondary heart ﬁelds from HH15 (6 h post-
treatment) and HH16 (12 h post-treatment) embryos that had been
treated with H2O or SAG at HH14 to qPCR. Ptc1 was signiﬁcantly up-
regulated at HH15 in response to SAG treatment, while Ptc2 was up-
regulated at HH16 (Fig. 5A), suggesting that the two genes have
different kinetic responses to hedgehog signaling. While the cell cycle
gene CCND1 was increased in culture (Fig. 2B), it was not increased in
vivo at either HH15 or 16 (Fig. 5). However, unlike the in vitro
experiment, the cardiac transcription factors Nkx2.5 and Mef2c were
signiﬁcantly up-regulated after the in vivo SAG treatment.
These data combined with the proliferation data suggested that
the in vivo proliferative response may be mitigated by signaling from
adjacent tissues. In order to identify adjacent tissues that have the
potential to dampen the in vivo response, secondary heart ﬁeld
explants were co-cultured with pharyngeal endoderm or outﬂow
tract explants in the presence or absence of SAG. Culturing the
secondary heart ﬁeld with SAG again induced a proliferative response,
which was blocked by co-culturing with pharyngeal endoderm or
outﬂow tract (Fig. 5B). Because increasing doses of SAG beyond a
certain dose result in reduced hedgehog signaling (Chen et al., 2002),
the lack of proliferation induced by SAG and endoderm, the
endogenous Shh source, is not surprising. Interestingly, outﬂow
tract co-cultures tended to promote myocardial differentiation in the
secondary heart ﬁeld explants even in the presence of SAG (Fig. 5C).
These data show that the outﬂow tract in particular alters prolifer-
ation and possibly differentiation in secondary heart ﬁeld explants in
the presence of SAG.
BMP2 is secreted by the outﬂow tract and has been shown to
inhibit Shh-induced proliferation in cerebellar granule cells (Alvarez-
Rodriguez et al., 2007), and both Nkx2.5 and Mef2c are downstream
targets of BMP signaling (Monzen et al., 1999; Prall et al., 2007; Qi et
al., 2007; Schultheiss et al., 1997; Shi et al., 2000). In mouse, BMP4 is
expressed throughout the outﬂow tract and into the splanchnic
mesoderm (Ilagan et al., 2006). In chick, BMP2 mRNA is expressed in
the outﬂow tract and the contiguous splanchnic mesoderm at HH14;
however, this expression does not extend throughout the secondary
heart ﬁeld (Waldo et al., 2001). We examined BMP2 protein
expression in control embryos at HH14-16. Similar to the mRNA
expression studies, BMP2 was expressed in the myocardium, the
Fig. 6. BMP signalingmodulates hedgehog signaling. (A)Mid-sagittal section through the foregut showing the junction of the outﬂowmyocardium (red) with the ventral pharyngeal
splanchnicmesoderm. The secondary heartﬁeld (SHF) is located caudal to the outﬂow tract (OFT). Cells can be seenmigrating from the SHF (green) to the outﬂow tract. (B) Schematic
showing the location of the SHFwith respect to theOFT and pharynx. Box illustrates area shown in C andD. (C,D) BMP2 immunohistochemistry indicates that BMP2 is expressed by the
myocardium and SHF near themyocardial OFT. (E) SAG up-regulates proliferation in explanted SHFmesodermwhile BMP2 downregulates proliferation in explants treated with SAG.
(F) SAG has no effect on myocardial differentiation while BMP2 promotes differentiation regardless of SAG treatment. *pb0.05 and **pb0.01 vs. control (co). IFT, inﬂow tract.
173L.A. Dyer et al. / Developmental Biology 348 (2010) 167–176endocardium, and the cranial-most secondary heart ﬁeld at HH16
(Figs. 6A-D).
To determine if BMP2 could dampen the SAG-induced prolifera-
tion, secondary heart ﬁeld explants were treated simultaneously with
SAG and BMP2. SAG treatment alone signiﬁcantly increased prolifer-
ation, as described above, and BMP2 treatment alone resulted in a
slight but non-signiﬁcant reduction in proliferation after either 24 or
48 h of culture (Fig. 6E). Instead, BMP2 treatment induced myocardial
differentiation, as reported previously (Waldo et al., 2001; Hutson
et al., 2010). Explants that were treated with both SAG and BMP2
showed the same proliferative response as controls, suggesting that
BMP counteracts hedgehog-induced proliferation. In addition, SAG
treatment alone did not promote myocardial differentiation, whereas
the presence of SAG and BMP2 signiﬁcantly increased myocardial
differentiation (Fig. 6F). Together, these data indicate that, in the
presence of up-regulated hedgehog and BMP signaling, the secondary
heart ﬁeld responds primarily to the BMP signal.
To evaluate whether BMP2 expression is upregulated in the distal
outﬂow tract by in vivo SAG treatment at HH14, we performed in situ
hybridization and qPCR. By HH16 BMP2 was dramatically elevated in
the distal outﬂow tract and the adjacent secondary heart ﬁeld of SAG-
treated embryos (Figs. 7E-H) compared to control embryos (Figs. 7A-
D). qPCR conﬁrmed that BMP2 was elevated 2.49 times in HH14/15
outﬂow tracts exposed to SAG compared with water-treated controls
(data not shown).
To determine whether SAG-induced proliferation in the secondary
heart ﬁeld could be dampened in vivo by BMP signaling, pSMAD1,5,8,
which is indicative of BMP activity, was analyzed immunohistochemi-
cally (Figs. 7I-N). At HH15, pSMADwas expressed in the outﬂow tract
myocardium and endocardium of the control embryos; pSMAD
expression was elevated in the secondary heart ﬁeld adjacent to the
outﬂow tract, where proliferation is normally decreased, as compared
to the more highly proliferative caudal secondary heart ﬁeld. After
SAG treatment at HH14, pSMAD expression at HH15 was greatly
reduced in the outﬂow tract and the secondary heart ﬁeld compared
to the control embryo, indicating that BMP signaling was dampened
in these cells. However, at HH16 pSMAD expression was elevated inthe secondary heart ﬁeld of SAG-treated embryos compared with
control embryos. Thus, after SAG treatment at HH13-14, BMP mRNA
expression was elevated at HH14-16, and BMP signaling increased by
HH16. This timing coincides with the later stages of myocardial
addition by the secondary heart ﬁeld.
Further, increased BMP signaling in the secondary heart ﬁeld was
accompanied by the appearance of prematurely or ectopically
differentiating myocardium in the secondary heart ﬁeld of most
SAG-treated embryos at HH16-18 (Table 2 and data not shown).
While some control embryos also had some ectopic myocardial cells
in the secondary heart ﬁeld, the SAG-treated embryos had signiﬁ-
cantly more ectopic MF20-positive cells within the secondary heart
ﬁeld (2.8±1.2 in HH16 controls vs. 9.6±5.1 in HH16 SAG-treated
embryos; pb0.05). The up-regulation of pSMAD expression in the
secondary heart ﬁeld coupled with the ectopic myocardial differen-
tiation suggests that BMP signaling via pSMAD dampens the
proliferative response to SAG and initiates premature myocardial
differentiation in the secondary heart ﬁeld.
To determine whether proliferation could be upregulated by SAG in
vivo by suppressing BMP signaling, we co-treated embryos with SAG
and the BMP inhibitor dorsomorphin. Unfortunately, these embryos
underwent early embryonic lethality (data not shown) prior to a time
whenwe could assesswhether inhibiting BMP signaling allowed SAG to
affect proliferation of the secondary heart ﬁeld progenitors.
Discussion
Our data show that up-regulated hedgehog signaling causes
increased proliferation of secondary heart ﬁeld progenitors if the
signal is unopposed by other signaling pathways. However, the
complex signaling feedback network that is present between various
tissues in vivo is not observed in the much simpler situation that can
be created in vitro. Thus, our in vivo results suggest that up-regulation
of hedgehog signaling leads to elevated BMP signaling by the outﬂow
tract and that this elevation in turn reduces the proliferative effect of
hedgehog signaling on the secondary heart ﬁeld progenitors. First,
elevated hedgehog signaling expands the proliferative niche within
Fig. 7. BMP signaling is elevated by SAG treatment. (A-H) In situ hybridization of BMP2 at HH16 in controls treated with water (A-D) and after SAG treatment (E-H) at HH14 shows
elevated expression around the junction of the distal outﬂow tract (OFT) with the pharynx. (I-N) BMP signaling in the secondary heart ﬁeld (SHF), as indicated by pSMAD1,5,8
expression at HH15, 16 and 17. Embryos were treated with water (Control, I, J, K) or SAG (L, M, N) at HH14, and pSMAD (brown/black) was analyzed at HH15-17. Control embryos
show robust pSMAD expression in the OFT myocardium and decreased expression throughout the SHF at HH15. After SAG treatment, HH15 embryos show decreased pSMAD
expression. pSMAD appears upregulated in the SHF and endoderm at HH16. By HH17, pSMAD expression appears the same in both control and SAG-treated embryos. IFT, inﬂow
tract.
Table 2
Number of embryos with ectopic myocardium in the secondary heart ﬁeld after in
controls (C) and after SAG treatment at HH14.
Stage C SAG
16 6/15 5/7*
17 0/9 5/10*
18 1/5 3/5*
*(pb0.05, Fisher exact test).
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can contribute to the myocardium at that stage. Then, elevated BMP
signaling represses the hedgehog-induced increase in proliferation
and leads to premature differentiation of the secondary heart ﬁeld-
derived myocardium. The end result to heart development is stenosis
of the systemic and pulmonary outlets possibly caused by abnormal
patterning of the outﬂow tract. This defect is in stark contrast with the
consequences of down-regulating hedgehog signaling, which results
in arterial pole defects limited to the pulmonary outlet including
pulmonary atresia/stenosis (Chiang et al., 1996; Dyer and Kirby, 2009;
Goddeeris et al., 2007; Washington Smoak et al., 2005). These results
show how Shh works in concert with other signaling pathways to
induce both proliferation and differentiation. Among the pathways
that are known to interact with Shh, we examined BMP because this
signaling pathway is important throughout heart development, fromthe initial induction of the cardiogenic mesoderm (Schultheiss et al.,
1997) to outﬂow tract cushion formation (Kim et al., 2001). In mouse,
BMP4 is expressed by the outﬂow tract myocardium, where it
175L.A. Dyer et al. / Developmental Biology 348 (2010) 167–176promotes myocardial differentiation by inducing Nkx2.5, Gata4, and
ventricular myosin heavy chain (Monzen et al., 1999; Schultheiss
et al., 1997; Shi et al., 2000). Because BMP4 is involved in so many
aspects of development, the BMP4-null mouse dies by E6.5 (Winnier
et al., 1995). Conditionally knocking out BMP4 under the Nkx2.5
promoter yields mice with an unseptated outﬂow tract (Liu et al.,
2004). The BMP2-null mouse is also embryonic lethal, with mice
dying at E8.5 due to cardiac developmental delays (Zhang and Evans,
1996) and impaired neural crest migration (Correia et al., 2007). In
chick, both BMP4 and BMP2 are present in the outﬂow tract (Somi
et al., 2004). Secondary heart ﬁeld explants treated with BMP2 induce
myocardial differentiation and decrease proliferation (Waldo et al.,
2001; Hutson et al., 2010).
Interactions between the Shh and BMP signaling pathways have
been previously observed during development. Cerebellar granular
neuron precursors (CGNPs) that are co-cultured with both Shh and
BMP2 show decreased proliferation in comparison with CGNPs that
are treated with Shh alone. Speciﬁcally, BMP2 down-regulates Shh
target n-myc, and this decrease is seen before changes are seen in
other Shh targets, such as Gli1 (Alvarez-Rodriguez et al., 2007). This
ability to inhibit proliferation is independent of BMP2's role in
promoting differentiation. Furthermore, application of BMP2 to either
chick feather germs or limb buds down-regulates Shh expression, and
application of the BMP2 inhibitor noggin up-regulates Shh expression
(Bastida et al., 2009; Harris et al., 2002). Shh can also affect the BMP
pathway. In the limb mesenchyme, BMP2 signaling is up-regulated in
response to exogenous Shh (Yang et al., 1997). Shh can also down-
regulate BMP4 in the limbmesenchyme, and this process is thought to
occur through Tbx3 (Tumpel et al., 2002). Recent evidence also
suggests that Shh induces BMP repressor Gremlin in the developing
limb bud (Benazet et al., 2009).
Based on these studies, we questioned whether BMP signaling was
altered after SAG treatment and how the secondary heart ﬁeld would
behave in response to alterations in both pathways. In the presence of
SAG alone, secondary heart ﬁeld explants proliferated more than
control explants, as expected. When treated with both SAG and BMP2,
explants behaved as BMP2-treated explants; proliferationwas slightly
but not signiﬁcantly decreased as compared to controls, and
myocardial differentiation increased. Other studies in our lab have
shown a signiﬁcant depression of secondary heart ﬁeld proliferation
by BMP2 (Hutson et al., 2010), and it is unclear why this was not the
case in this study. The secondary heart ﬁeld serves as a progenitor
pool that must generate sufﬁcient myocardium and smooth muscle to
form the arterial pole. The BMP2 differentiation signal balances the
Shh-induced proliferation, ensuring the gradual addition of secondary
heart ﬁeld-derived myocardial cells to the outﬂow tract thus ensuring
normal arterial pole development.
We have shown that BMP2 and Shh exert opposing effects to
maintain a speciﬁc region of proliferation within the secondary heart
ﬁeld and coordinate proliferation with differentiation and outﬂow
patterning. When hedgehog signaling is up-regulated, BMP is up-
regulated and inhibits hedgehog-induced proliferation. The BMP
overrides other signaling that maintains the progenitor pool and
induces ectopic myocardium.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.09.021.
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